Pathstone Family Office’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$17.9K Buy
+13,029
New +$17.9K ﹤0.01% 1647